Abliva Competitors and Similar CompaniesClear all
Abliva's competitors and similar companies include Molecular Partners and Brii Biosciences.
 Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. | |
Founding Date | Founding Date 2000 | Founding Date 2004 | Founding Date 2018 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US |
Employees | Employees 950% increase | Employees 158 | Employees 8510% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr497k (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income (kr90m) (FY, 2024) | Net income (CHF61.7m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 10.8m | Total funding raised N/A | Total funding raised $ 415m |
For sources of this data, please see the company profile
View Company Profiles
Molecular Partners
HQ
Zürich-Schlieren, CH
Employees
158
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View companyBrii Biosciences
HQ
CN
Employees
85↓ 10% decrease
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View company